ICO
ICO
Saint-Herblain, France2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS) | Oligometastatic Prostate Cancer (OMPC); Prostate Cancer Metastatic Disease | Recruiting | Not applicable | 2026-06-04 | NCT06978296 | |
| Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736) | Bone Metastases; Node; Prostate; Prostate Cancer Patients | Active, not recruiting | Phase 2 | 2026-03-31 | NCT03795207 |